DK0863880T3 - New, anti-convulsant-acting 1-ar (alk) yl imidazolin-2-ones containing a disubstituted amine residue at the 4-position, and process for their preparation - Google Patents

New, anti-convulsant-acting 1-ar (alk) yl imidazolin-2-ones containing a disubstituted amine residue at the 4-position, and process for their preparation

Info

Publication number
DK0863880T3
DK0863880T3 DK96927607T DK96927607T DK0863880T3 DK 0863880 T3 DK0863880 T3 DK 0863880T3 DK 96927607 T DK96927607 T DK 96927607T DK 96927607 T DK96927607 T DK 96927607T DK 0863880 T3 DK0863880 T3 DK 0863880T3
Authority
DK
Denmark
Prior art keywords
convulsant
imidazolin
alk
acting
preparation
Prior art date
Application number
DK96927607T
Other languages
Danish (da)
Inventor
Manfred Menzer
Karl Gewald
Harry Schaefer
Hans-Joachim Lankau
Klaus Unverferth
Original Assignee
Elbion Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0863880(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elbion Ag filed Critical Elbion Ag
Application granted granted Critical
Publication of DK0863880T3 publication Critical patent/DK0863880T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK96927607T 1995-09-05 1996-07-26 New, anti-convulsant-acting 1-ar (alk) yl imidazolin-2-ones containing a disubstituted amine residue at the 4-position, and process for their preparation DK0863880T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (en) 1995-09-05 1995-09-05 Novel, anticonvulsant 1-ar (alk) yl-imidazolin-2-ones which contain a disubstituted amine radical in the 4-position, and process for their preparation
PCT/EP1996/003295 WO1997009314A1 (en) 1995-09-05 1996-07-26 Novel 1-ar(alk)yl-imidazolin-2-ones containing a disubstituted amine radical in the 4th position, having an anti-convulsive effect, and process for their production

Publications (1)

Publication Number Publication Date
DK0863880T3 true DK0863880T3 (en) 2004-03-22

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96927607T DK0863880T3 (en) 1995-09-05 1996-07-26 New, anti-convulsant-acting 1-ar (alk) yl imidazolin-2-ones containing a disubstituted amine residue at the 4-position, and process for their preparation

Country Status (32)

Country Link
EP (1) EP0863880B1 (en)
JP (1) JP4030578B2 (en)
CN (1) CN1103762C (en)
AR (1) AR003502A1 (en)
AT (1) ATE254606T1 (en)
AU (1) AU700602B2 (en)
BG (1) BG63917B1 (en)
BR (1) BR9610359A (en)
CA (1) CA2184871C (en)
CZ (1) CZ291839B6 (en)
DE (2) DE19532668A1 (en)
DK (1) DK0863880T3 (en)
EA (1) EA000535B1 (en)
EE (1) EE03562B1 (en)
ES (1) ES2208758T3 (en)
FR (1) FR13C0049I2 (en)
GE (1) GEP20022652B (en)
HK (1) HK1015776A1 (en)
HU (1) HU225956B1 (en)
IL (1) IL123333A (en)
LT (1) LT4482B (en)
LU (1) LU92263I2 (en)
NO (1) NO313829B1 (en)
NZ (1) NZ315624A (en)
PL (1) PL188287B1 (en)
PT (1) PT863880E (en)
SK (1) SK284868B6 (en)
TR (1) TR199800476T1 (en)
TW (1) TW422838B (en)
UA (1) UA46790C2 (en)
WO (1) WO1997009314A1 (en)
ZA (1) ZA967014B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (en) * 1997-05-23 1998-11-26 Dresden Arzneimittel Use of 1-ar (alk) yl-imidazolin-2-one for the treatment of anxiety and tension
US20050070537A1 (en) * 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
MXPA05013196A (en) * 2003-07-11 2006-03-09 Elbion Ag Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor.
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
JP2014521714A (en) 2011-08-12 2014-08-28 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング Odd isomer current (If) inhibitors for use in methods of treating and preventing feline heart failure
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (en) 2021-01-18 2022-07-18 Procos Spa PROCESS FOR THE SYNTHESIS OF IMEPITOIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790380A (en) 1971-10-21 1973-04-20 American Cyanamid Co NEW (P-CHLORO) PHENYL-1 METHYL-3 IMIDAZOLIDINES, 2,4-DISUBSTITUTIONS USEFUL IN PARTICULAR AS ANTIALDOSTERONE DIURETIC AGENTS AND THEIR PREPARATION PROCESS
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
NO980906D0 (en) 1998-03-02
ZA967014B (en) 1997-08-18
EA000535B1 (en) 1999-10-28
HK1015776A1 (en) 1999-10-22
CN1103762C (en) 2003-03-26
CA2184871A1 (en) 1997-03-06
CA2184871C (en) 2001-08-21
TR199800476T1 (en) 1998-06-22
JPH11512101A (en) 1999-10-19
NO313829B1 (en) 2002-12-09
CN1200728A (en) 1998-12-02
DE59610827D1 (en) 2003-12-24
DE19532668A1 (en) 1997-03-06
SK284868B6 (en) 2006-01-05
EE03562B1 (en) 2001-12-17
PL188287B1 (en) 2005-01-31
HUP9802941A2 (en) 1999-09-28
ES2208758T3 (en) 2004-06-16
FR13C0049I1 (en) 2013-09-27
BR9610359A (en) 1999-07-06
LT98047A (en) 1998-10-26
NZ315624A (en) 1998-11-25
ATE254606T1 (en) 2003-12-15
IL123333A (en) 2001-10-31
CZ291839B6 (en) 2003-06-18
PL325413A1 (en) 1998-07-20
SK21698A3 (en) 1998-10-07
BG63917B1 (en) 2003-06-30
GEP20022652B (en) 2002-03-25
PT863880E (en) 2004-04-30
BG102287A (en) 1998-09-30
AU700602B2 (en) 1999-01-07
LU92263I2 (en) 2013-10-07
LT4482B (en) 1999-03-25
AU6737596A (en) 1997-03-27
TW422838B (en) 2001-02-21
HU225956B1 (en) 2008-01-28
JP4030578B2 (en) 2008-01-09
EA199800271A1 (en) 1998-10-29
NO980906L (en) 1998-03-02
EP0863880A1 (en) 1998-09-16
EP0863880B1 (en) 2003-11-19
FR13C0049I2 (en) 2014-03-28
EE9800063A (en) 1998-08-17
IL123333A0 (en) 1998-09-24
WO1997009314A1 (en) 1997-03-13
CZ66198A3 (en) 1998-07-15
UA46790C2 (en) 2002-06-17
HUP9802941A3 (en) 1999-10-28
AR003502A1 (en) 1998-08-05
MX9801742A (en) 1998-08-30

Similar Documents

Publication Publication Date Title
DK0855999T3 (en) 1- (1,2-Disubstituted piperidinyl) -4-substituted piperidine derivatives as tachykinin receptor antagonists
DK0862566T3 (en) 1- (1,2-Disubstituted piperidinyl) -4-substituted piperazine derivatives
NO964700D0 (en) Novel amino acid derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
TR199600930A2 (en) Crystalline structure (R) - (-) - 2- {N- £ 4- (1,1-dioxido-3-oxo-2, 3-dihydrobenzisothiazol-2-yl) -butyl | - aminomethyl} -chromane hydrochloride.
NO20005224L (en) BTK inhibitors and methods for their identification and use
DK0736130T3 (en) Procedure for preventing gas hydrates from clogging wires
DE3784669D1 (en) DEVICE FOR ATTACHING A REPLACEMENT RAIL WHICH PROVIDES A PROGRAMMED MOVEMENT WITHOUT INTERRUPTING SUCH A MOVEMENT.
DK0858440T3 (en) Process for preparing 1,1,1,3,3-pentafluoropropane
DK0843679T3 (en) 1- (1,2-Disubstituted Piperidinyl) -4- (Condensed Midazole) Piperidine Derivatives
DK1045856T3 (en) Novel aromatic amides, processes for their preparation and their use as pharmaceuticals
NO985671L (en) New Thiazolidinedione-2 derivatives which are 4-diketone substituted process
AR004368A1 (en) SUBSTITUTED PIPERIDINE -1, -4 COMPOUNDS, PROCEDURES FOR PREPARING THEM AND A PROCEDURE FOR PREPARING 1-BENCIL-4 - ((5,6-DIMETOXI-1-INDANON) -2-IL) METHYLPIPERIDINE THROUGH THESE COMPOUNDS.
DK0863880T3 (en) New, anti-convulsant-acting 1-ar (alk) yl imidazolin-2-ones containing a disubstituted amine residue at the 4-position, and process for their preparation
DK1015421T3 (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals
DK0838469T3 (en) 10,13,15-Trioxatricyclo (9.2.1 9.6) -pentadecanone derivatives, process for their preparation, and drugs containing these compounds
NO20002588L (en) Bifenylamidinderivater
NO944680D0 (en) New thienothiazine derivatives, a process for their preparation and their use
DK0946579T3 (en) New compounds derived from erythromycin, methods for their preparation and their use as drugs
ITVI910109A0 (en) PRESSURE REGULATOR FOR GAS.
NO20000199L (en) Medications containing polyhydroxybutylpyrazines, new polyhydroxybutylpyrazines and their preparation
DK0452850T3 (en) 4- [3- (Oxothiazoldinyl)] butynylamines, process for their preparation and their use as pharmaceuticals
DK0820440T3 (en) New carbamate compounds having an N-substituted thiocarbamoyl group and process for their preparation
NO980309D0 (en) Novel, anti-convulsive imidazoline-2,4-dione with an ortho-substituted ar (alk) yl residue at the 1-position, and their preparation
DK0670020T3 (en) Holding element for pressure line connections
DK1293506T3 (en) New 1- [1- (hetero) aryl-1-perhydroxyalkylmethyl] -piperazine compounds, process for their preparation, and drugs containing these compounds